Wild type and SH2D2A-deficient Id-specific TCR-transgenic mice as well as wild-type and SH2D2A-deficient non-TCR transgenic BALB/c mice were injected s.c. with a low dose of MOPC315 myeloma cells (0,16×106 cells). This evidence concerns the gene SH2D2A and plasma cell myeloma.